Atlas Trials

A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia

Clinical trial NCT07229937 · RECRUITING

Trial details

NCT number
NCT07229937
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Hyperlipidemia
Start date
2025-11-25
Primary completion
2026-08-01
Enrollment
189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.